protein level expression data Search Results


90
BioMimetic Therapeutics protein expression levels of bax
Protein Expression Levels Of Bax, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/protein+expression+levels+of+bax/pmc11383433-282-5-13
Average 90 stars, based on 1 article reviews
protein expression levels of bax - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
DiaGenic ASA protein expression levels
Protein Expression Levels, supplied by DiaGenic ASA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/protein+expression+levels/us09702852-816-20-23
Average 90 stars, based on 1 article reviews
protein expression levels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Epigenomics ag expression data of protein-coding genes for pbmcs
Expression Data Of Protein Coding Genes For Pbmcs, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/expression+data+of+protein+coding+genes+for+pbmcs/pm29924591-221-6-12
Average 90 stars, based on 1 article reviews
expression data of protein-coding genes for pbmcs - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SomaLogic protein expression data from the panel of 1129 proteins measured by
Protein Expression Data From The Panel Of 1129 Proteins Measured By, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/protein+expression+data+from+the+panel+of+1129+proteins+measured+by/10__1158_slash_2326___6066__cir___17___0412-77-23-26
Average 90 stars, based on 1 article reviews
protein expression data from the panel of 1129 proteins measured by - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Rosetta Biosoftware elucidator protein expression data analysis system version 3.3
Elucidator Protein Expression Data Analysis System Version 3.3, supplied by Rosetta Biosoftware, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/elucidator+protein+expression+data+analysis+system+software/pmc03153440-117-9-18
Average 90 stars, based on 1 article reviews
elucidator protein expression data analysis system version 3.3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Gallus BioPharmaceuticals protein expression data
Protein Expression Data, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/protein+expression+data/pmc11343375-5-16-65
Average 90 stars, based on 1 article reviews
protein expression data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SMAC Corp diablo/smac protein expression levels
Diablo/Smac Protein Expression Levels, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/diablo+smac+protein+expression+levels/pmc06026322-224-67-67
Average 90 stars, based on 1 article reviews
diablo/smac protein expression levels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc normalized protein expression data
Normalized Protein Expression Data, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/protein+normalized+expression+data/pmc06906458-205-1-12
Average 90 stars, based on 1 article reviews
normalized protein expression data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CH Instruments p16 protein expression level
Immunohistochemical staining for <t>p16</t> protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.
P16 Protein Expression Level, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/p16+protein+expression+level/pmc10505467-135-0-5
Average 90 stars, based on 1 article reviews
p16 protein expression level - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Epigenomics ag rpkm expression data for protein-coding exons
Immunohistochemical staining for <t>p16</t> protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.
Rpkm Expression Data For Protein Coding Exons, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/rpkm+expression+data+for+protein+coding+exons/pmc06107638-245-11-19
Average 90 stars, based on 1 article reviews
rpkm expression data for protein-coding exons - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc sclc cell line reverse phase proteomic array (rppa) protein expression data
Immunohistochemical staining for <t>p16</t> protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.
Sclc Cell Line Reverse Phase Proteomic Array (Rppa) Protein Expression Data, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/sclc+cell+line+reverse+phase+proteomic+array++rppa++protein+expression+data/pm40114214-123-0-19
Average 90 stars, based on 1 article reviews
sclc cell line reverse phase proteomic array (rppa) protein expression data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc hnscc tcga normalized tcga hnscc gene expression and protein expression (rppa) data
Immunohistochemical staining for <t>p16</t> protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.
Hnscc Tcga Normalized Tcga Hnscc Gene Expression And Protein Expression (Rppa) Data, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+level+expression+data/hnscc+tcga+normalized+tcga+hnscc+gene+expression+and+protein+expression++rppa++data/pm40382983-170-16-24
Average 90 stars, based on 1 article reviews
hnscc tcga normalized tcga hnscc gene expression and protein expression (rppa) data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Immunohistochemical staining for p16 protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.

Journal: Reports of Biochemistry & Molecular Biology

Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma

doi: 10.52547/rbmb.12.1.83

Figure Lengend Snippet: Immunohistochemical staining for p16 protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.

Article Snippet: Parameters P16 Protein Expression Level P-value(Chi-Square) Negative (n = 29) Low-Positive (n = 44) High-Positive (n = 27) ER receptor Positive 22 (75.9%) 41 (93.2%) 17 (63%) 0.007* Negative 7 (24.1%) 3 (6.8%) 10 (37%) PR receptor Positive 14 (48.3%) 33 (75%) 16 (59.3%) 0.061 Negative 15 (51.7%) 11 (25%) 11 (40.7%) HER2 Positive 4 (13.8%) 15 (34.1%) 11 (40.7%) 0.065 Negative 25 (86.2%) 29 (65.9%) 16 (59.3%) Ki67 Positive (> 14%) 7 (24.1%) 16 (36.4%) 5 (18.5%) 0.229 Negative (≤ 14%) 22 (75.9%) 28 (63.6%) 22 (81.5%) Cancer Grade I 2 (6.9%) 2 (4.5%) 4 (14.8%) 0.252 II 20 (69%) 37 (84.1%) 17 (6%) III 7 (24.1%) 5 (11.4%) 6 (22.2%) Tumor Size ≤ 20 mm 11 (37.9%) 18 (40.9%) 13 (48.1%) 0.754 21-50 mm 18 (62.1%) 25 (56.8%) 14 (51.9%) > 50 mm 0 (0%) 1 (2.3%) 0 (0%) Cancer Type Luminal A 7 (29.16%) 13 (54.16%) 4 (16.66%) 0.144 Luminal B 15 (26.31%) 28 (49.12%) 14 (24.56%) HER2 positive 2 (28.57%) 1 (14.28%) 4 (57.14%) Triple Negative 5 (41.66%) 2 (16.66%) 5 (41.66%) Age ≤ 40 years 7 (24.1%) 11 (25%) 10 (37%) 0.471 > 40 yea 22 (75.9%) 33 (75%) 17 (63%) Family History Yes 5 (17.2%) 11 (25%) 5 (18.5%) 0.68 No 24 (82.8%) 33 (75%) 22 (81.5%) Open in a separate window The data are shown as mean ± SD.

Techniques: Immunohistochemical staining, Staining

Correlation between clinicopathological characteristics and  p16  protein expression in women with invasive ductal breast carcinoma.

Journal: Reports of Biochemistry & Molecular Biology

Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma

doi: 10.52547/rbmb.12.1.83

Figure Lengend Snippet: Correlation between clinicopathological characteristics and p16 protein expression in women with invasive ductal breast carcinoma.

Article Snippet: Parameters P16 Protein Expression Level P-value(Chi-Square) Negative (n = 29) Low-Positive (n = 44) High-Positive (n = 27) ER receptor Positive 22 (75.9%) 41 (93.2%) 17 (63%) 0.007* Negative 7 (24.1%) 3 (6.8%) 10 (37%) PR receptor Positive 14 (48.3%) 33 (75%) 16 (59.3%) 0.061 Negative 15 (51.7%) 11 (25%) 11 (40.7%) HER2 Positive 4 (13.8%) 15 (34.1%) 11 (40.7%) 0.065 Negative 25 (86.2%) 29 (65.9%) 16 (59.3%) Ki67 Positive (> 14%) 7 (24.1%) 16 (36.4%) 5 (18.5%) 0.229 Negative (≤ 14%) 22 (75.9%) 28 (63.6%) 22 (81.5%) Cancer Grade I 2 (6.9%) 2 (4.5%) 4 (14.8%) 0.252 II 20 (69%) 37 (84.1%) 17 (6%) III 7 (24.1%) 5 (11.4%) 6 (22.2%) Tumor Size ≤ 20 mm 11 (37.9%) 18 (40.9%) 13 (48.1%) 0.754 21-50 mm 18 (62.1%) 25 (56.8%) 14 (51.9%) > 50 mm 0 (0%) 1 (2.3%) 0 (0%) Cancer Type Luminal A 7 (29.16%) 13 (54.16%) 4 (16.66%) 0.144 Luminal B 15 (26.31%) 28 (49.12%) 14 (24.56%) HER2 positive 2 (28.57%) 1 (14.28%) 4 (57.14%) Triple Negative 5 (41.66%) 2 (16.66%) 5 (41.66%) Age ≤ 40 years 7 (24.1%) 11 (25%) 10 (37%) 0.471 > 40 yea 22 (75.9%) 33 (75%) 17 (63%) Family History Yes 5 (17.2%) 11 (25%) 5 (18.5%) 0.68 No 24 (82.8%) 33 (75%) 22 (81.5%) Open in a separate window The data are shown as mean ± SD.

Techniques: Expressing

Correlation of  p16  expression with tumor grade and age of patients with invasive ductal breast carcinoma. The data are shown as mean ± SD.

Journal: Reports of Biochemistry & Molecular Biology

Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma

doi: 10.52547/rbmb.12.1.83

Figure Lengend Snippet: Correlation of p16 expression with tumor grade and age of patients with invasive ductal breast carcinoma. The data are shown as mean ± SD.

Article Snippet: Parameters P16 Protein Expression Level P-value(Chi-Square) Negative (n = 29) Low-Positive (n = 44) High-Positive (n = 27) ER receptor Positive 22 (75.9%) 41 (93.2%) 17 (63%) 0.007* Negative 7 (24.1%) 3 (6.8%) 10 (37%) PR receptor Positive 14 (48.3%) 33 (75%) 16 (59.3%) 0.061 Negative 15 (51.7%) 11 (25%) 11 (40.7%) HER2 Positive 4 (13.8%) 15 (34.1%) 11 (40.7%) 0.065 Negative 25 (86.2%) 29 (65.9%) 16 (59.3%) Ki67 Positive (> 14%) 7 (24.1%) 16 (36.4%) 5 (18.5%) 0.229 Negative (≤ 14%) 22 (75.9%) 28 (63.6%) 22 (81.5%) Cancer Grade I 2 (6.9%) 2 (4.5%) 4 (14.8%) 0.252 II 20 (69%) 37 (84.1%) 17 (6%) III 7 (24.1%) 5 (11.4%) 6 (22.2%) Tumor Size ≤ 20 mm 11 (37.9%) 18 (40.9%) 13 (48.1%) 0.754 21-50 mm 18 (62.1%) 25 (56.8%) 14 (51.9%) > 50 mm 0 (0%) 1 (2.3%) 0 (0%) Cancer Type Luminal A 7 (29.16%) 13 (54.16%) 4 (16.66%) 0.144 Luminal B 15 (26.31%) 28 (49.12%) 14 (24.56%) HER2 positive 2 (28.57%) 1 (14.28%) 4 (57.14%) Triple Negative 5 (41.66%) 2 (16.66%) 5 (41.66%) Age ≤ 40 years 7 (24.1%) 11 (25%) 10 (37%) 0.471 > 40 yea 22 (75.9%) 33 (75%) 17 (63%) Family History Yes 5 (17.2%) 11 (25%) 5 (18.5%) 0.68 No 24 (82.8%) 33 (75%) 22 (81.5%) Open in a separate window The data are shown as mean ± SD.

Techniques: Expressing